Noradrenaline and its end metabolite 3-methoxy-4-hydroxyphenylglycol inhibit lymphocyte chemotaxis: Role of alpha- and beta-adrenoreceptors

Molecular and Cellular Biochemistry

Volumn 254, Issue 1-2, 2003, Pages 305-309

  García, Juan José ^a   Sáez, María del Carmen ^a   De la Fuente, Mónica ^b   Ortega, Eduardo ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

3 methoxy 4 hydroxyphenylglycol; Chemotaxis; Lymphocyte; Noradrenaline

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; NORADRENALIN; PHENTOLAMINE; PROPRANOLOL;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CHEMOTAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; METABOLITE; MOUSE; NONHUMAN; SPLEEN; STATISTICAL ANALYSIS; THYMUS;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; LYMPHOCYTES; METHOXYHYDROXYPHENYLGLYCOL; MICE; MICE, INBRED BALB C; NOREPINEPHRINE; PHENTOLAMINE; PROPRANOLOL; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; SPLEEN; THYMUS GLAND;

ANIMALIA;

EID: 17344387166     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027349904589     Document Type: Article

References (24)

1. Besedovsky HO, del Rey A, Sorkin E, da Prada M, Keller HH: Immunoregulation mediated by the sympathetic nervous system. Cell Immunol 48: 346-355, 1979
2. Blalock JE: The syntax of immune-neuroimmune communication. Immunol Today 15: 504-511, 1994
3. Fabris N: Immune system and aging: Neuroimmunological implications. Int J Immunopath Pharmacol 5: 93-102, 1992
4. Friedman EM, Irwin MR: Modulation of immune cell function by the autonomic nervous system. Pharmacol Ther 74: 27-38, 1997
5. Felten SY, Olschowka JA: Noradrencrgic sympathetic innervation of the spleen: II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp. J Neurosci Res 8: 37-48, 1987
6. Tang Y, Shankar R, Gamelli R, Jones S: Dynamic norepinephrine alterations in bone marrow: evidence of functional innervation. J Neuroimmunol 96: 182-189, 1999
7. Madden KS, Livnat S: Catecholamine action and immunologic reactivity. In: R. Ader, D.L. Felten, N. Cohen (eds). Psychoneuroimmunology, 2nd edn. Academic Press, San Diego, 1991, pp 283-310
8. Sáez MC, García JJ, De la Fuente M, Ortega E: Modulation of superoxide anion levels of macrofages from young-adult and old mice by the norepinephrine metabolite 4-hydroxy-3-metoxyphenyl-glycol. Exp Gerontol 37: 395-400, 2002
9. Ortega E, Galán M, De la Fuente M, Barriga C: Influence of physical activity stress and age on the ADCC of lymphocytes from mice. Arch Gerontol Geriat 16: 93-101, 1993
10. Boyden SV: The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocyte. J Exp Med 115: 453-456, 1962
11. Carrasco M, Del Rio M, Hernanz A, De la Fuente M: Inhibition of human neutrophil function by sulfated and nonsulfated cholecystokinin octapeptides. Peptides 18: 415-422, 1997
12. Del Rio M, De la Fuente M: Chemoattractant capacity of bombesin, gastrin-releasing peptide and neuromedin C is mediated through PKC activation in murine peritoneal leukocytes. Regul Pept 49: 185-193, 1994
13. Hugli TE: Chemotaxis. Curr Opin Immunol 2: 19-27, 1989
14. Roszman TL, Carlson SL: Neurotransmitters and molecular signalling in the immune response. In: R. Ader, D.L. Felten, N. Cohen (eds). Psychoneuroimmunology, 2nd edn. Academic Press, San Diego, 1991, pp 331-335
15. Ackerman KD, Felten SV, Bellinger DL, Livnat S, Felten DL: Noradrenergic sympathetic innervation of spleen and lymph nodes in relation to specific cellular compartments. In: B. Cinader, R.G. Miller (eds). Progress in Immunology IV. Academic Press, Florida, 1987, pp 588-600
16. Fernandez HN, Henson PM, Otani A, Hugli TE: Chemotactic response to human C3a and C5a anaphilotoxins. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol 120: 109-115, 1978
17. Ford-Hutchinson AW, Bray MA, Doig MU, Shipley ME, Smith MJH: Leukotriene B, a potent chemokinetic and aggregating substance release from polymorphonuclear leukocytes. Nature 286: 264-265, 1980
18. Shubert T, Müller WE: N-formyl-methionyl-leucyl-phenylalanine induced accumulation of inositol phosphates indicates the presence of oligopeptide chemoattractant receptors on circulating lymphocytes. FEBS Lett 257: 174-176, 1989
19. Chambers DA, Cohen RL, Perlman RL: Neuroimmune modulation: Signal transduction and catecholamines. Neurochem Int 22: 95-110, 1993
20. Silvestri M, Oddera S, Lantero S, Rossi GA: Beta 2-agonist-induced inhibition of neutrophil chemotaxis is not associated with modification of LFA-1 and Mac-1 expression or with impairment of polymorphonuclear leukocyte antibacterial activity. Resp Med 93: 416-423, 1999
21. Ortega E, Garcia JJ, Sáez MC, De la Fuente M: Changes with aging in the modulation of macrophages by norepinephrine. Mech Ageing and Dev 188: 103-114, 2000
22. Hadden JW, Hadden EM, Middleton E: Lymphocyte blast transformation-I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol 1: 583-595, 1970
23. Rasmussen AM, Hauger RL, Morgan CA, Bremner JD, Charney DS, Soutwick SM: Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry 47: 526-539, 2000
24. Benschop RJ, Rodríguez-Feuerhahn M, Schedlowski M: Catecholamine-induced leukocytosis: Early observations, current research, and future directions. Brain Behav Immun 10: 77-91, 1996